Profund Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
16,210
-7,396
| -31% | -$83.1K | 0.01% | 925 |
|
|
2025
Q1 | $108K | Sell |
23,606
-3,028
| -11% | -$13.8K | ﹤0.01% | 947 |
|
|
2024
Q4 | $150K | Sell |
26,634
-14,757
| -36% | -$83.2K | 0.01% | 1042 |
|
|
2024
Q3 | $200K | Buy |
41,391
+13,477
| +48% | +$65.2K | 0.01% | 1053 |
|
|
2024
Q2 | $136K | Sell |
27,914
-38,883
| -58% | -$190K | 0.01% | 1026 |
|
|
2024
Q1 | $887K | Buy |
66,797
+17,406
| +35% | +$231K | 0.03% | 390 |
|
|
2023
Q4 | $689K | Buy |
49,391
+2,298
| +5% | +$32K | 0.03% | 421 |
|
|
2023
Q3 | $624K | Buy |
47,093
+3,491
| +8% | +$46.3K | 0.03% | 406 |
|
|
2023
Q2 | $818K | Sell |
43,602
-5,125
| -11% | -$96.1K | 0.04% | 370 |
|
|
2023
Q1 | $703K | Buy |
+48,727
| New | +$703K | 0.04% | 400 |
|